BioStem Technologies's total assets for Q4 2024 were $140.55M, an increase of 34.88% from the previous quarter. BSEM total liabilities were $99.67M for the fiscal quarter, a 22.50% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.